| 1 | hiv and the law | | | | | | | 9 | 1.02% |
| 2 | global commission on hiv | | | | | | | 8 | 0.90% |
| 3 | commission on hiv and | | | | | | | 8 | 0.90% |
| 4 | on hiv and the | | | | | | | 7 | 0.79% |
| 5 | lawglobal commission on hiv | | | | | | | 4 | 0.45% |
| 6 | the global commission on | | | | | | | 3 | 0.34% |
| 7 | hiv and the lawglobal | | | | | | | 3 | 0.34% |
| 8 | the lawglobal commission on | | | | | | | 3 | 0.34% |
| 9 | articles and speeches from | | | | | | | 2 | 0.23% |
| 10 | europe and central asia | | | | | | | 2 | 0.23% |
| 11 | progress on the 101010 | | | | | | | 2 | 0.23% |
| 12 | people living with hiv | | | | | | | 2 | 0.23% |
| 13 | eastern europe and central | | | | | | | 2 | 0.23% |
| 14 | africa high income countries | | | | | | | 2 | 0.23% |
| 15 | and the lawglobal commission | | | | | | | 2 | 0.23% |
| 16 | living with hiv and | | | | | | | 2 | 0.23% |
| 17 | in the way of | | | | | | | 2 | 0.23% |
| 18 | standing in the way | | | | | | | 2 | 0.23% |
| 19 | the way of success | | | | | | | 1 | 0.11% |
| 20 | and the law undertook | | | | | | | 1 | 0.11% |
| 21 | the law undertook 18 | | | | | | | 1 | 0.11% |
| 22 | law undertook 18 months | | | | | | | 1 | 0.11% |
| 23 | undertook 18 months of | | | | | | | 1 | 0.11% |
| 24 | analysis and deliberation its | | | | | | | 1 | 0.11% |
| 25 | extensive research consultation analysis | | | | | | | 1 | 0.11% |
| 26 | research consultation analysis and | | | | | | | 1 | 0.11% |
| 27 | consultation analysis and deliberation | | | | | | | 1 | 0.11% |
| 28 | obstacles are standing in | | | | | | | 1 | 0.11% |
| 29 | and deliberation its sources | | | | | | | 1 | 0.11% |
| 30 | included the testimony of | | | | | | | 1 | 0.11% |
| 31 | the testimony of more | | | | | | | 1 | 0.11% |
| 32 | testimony of more than | | | | | | | 1 | 0.11% |
| 33 | of more than 700 | | | | | | | 1 | 0.11% |
| 34 | are standing in the | | | | | | | 1 | 0.11% |
| 35 | read the report contact | | | | | | | 1 | 0.11% |
| 36 | political obstacles are standing | | | | | | | 1 | 0.11% |
| 37 | new hiv infections and | | | | | | | 1 | 0.11% |
| 38 | evidence and tools we | | | | | | | 1 | 0.11% |
| 39 | and tools we need | | | | | | | 1 | 0.11% |
| 40 | tools we need to | | | | | | | 1 | 0.11% |